Contego’s Neuroguard IEP System Used in First Commercial Procedures – Endovascular Today
December 19, 2024—Contego Medical announced the first commercial procedures were performed with the company’s Neuroguard IEP system. Ac
December 19, 2024—Contego Medical announced the first commercial procedures were performed with the company’s Neuroguard IEP system. Ac
Cardioneuroablation (CNA) is an emerging technique that aims to block the postganglionic vagal fibers of the heart, correcting the imbalance between sympathetic and parasympathetic tone.…
BackgroundA multidisciplinary approach improves guideline‐directed medical therapy in systolic heart failure (HF), but its efficacy in patients with HF due to cardiac sarcoidosis is unreported.Meth…
Current diagnostic criteria for left ventricular noncompaction (LVNC) may be poorly related to adverse prognosis. Late gadolinium enhancement (LGE) is a predictor of major adverse…
With your help, ACC Advocacy actively works with Congress, state legislators, and other key decision makers to transform cardiovascular care and improve heart health. However,…
Abstract. This State of the Future Review describes and discusses the potential transformative power of digital twins in cardiac electrophysiology. In this
Congress is currently considering year-end legislation to prevent a government shutdown. They must pass legislation today, Friday, December 20, as government funding will expire at…
Support our cause by donating to Year End Campaign 2024.
Ronnie O’Sullivan swept past Ding Junhui with a resounding win to reach the semi-finals of the Riyadh Season Snooker Championship.
Heart failure is associated with a very high hospital readmission rate, which is burdensome and costly for patients, hospitals, and healthcare systems. Earli…
December 19, 2024—Biotronik announced the enrollment of the first patients in its BIO-OSCAR FIRST trial, which is designed to confirm the safety